ÂÜÀòÂÒÂ×

Ashley Cate currently serves as the Director of FP&A at Standard BioTools, following a merger with SomaLogic in January 2024, where Ashley held the position of Associate Director, Finance. Prior to that, Ashley was with Thermo Fisher Scientific for over five years, advancing from Financial Analyst III to Senior Finance Manager, focusing on driving business growth and supporting strategic financial initiatives. Earlier experience includes a role as Financial Planning & Analysis Analyst at Wyndham Destinations, and an internship at Johnson & Johnson. Ashley holds a Bachelor of Science degree in Accounting and Finance from the University of South Carolina Darla Moore School of Business.